Ascend Wellness Holdings (AAWH) Cost of Revenue (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Cost of Revenue came in at $72.1 million in Q1 2026, down 18.53% year-on-year from $88.4 million in Q1 2025, and down 4.47% quarter-over-quarter from $75.4 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Cost of Revenue (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Cost of Revenue history runs 7 years deep, the most recent figure standing at $72.1 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 18.53% year-over-year to $72.1 million in Q1 2026; TTM through Mar 2026 was $314.5 million, a 16.23% decrease from a year earlier, with the FY2025 full-year figure at $330.9 million, down 12.32% from the prior year.
  • Cost of Revenue declined to $72.1 million in Q1 2026 per AAWH's latest filing, from $75.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $100.0 million in Q2 2024 and bottomed at $61.6 million in Q1 2022.
  • The 5-year median for Cost of Revenue is $85.9 million (2025), against an average of $83.2 million.
  • Across the five-year window, Cost of Revenue soared 69.02% in 2022 and decreased 18.53% in 2026, its largest moves.
  • Year by year, Cost of Revenue stood at $70.6 million in 2022, then jumped by 31.21% to $92.6 million in 2023, then decreased by 3.76% to $89.1 million in 2024, then fell by 15.39% to $75.4 million in 2025, then fell by 4.47% to $72.1 million in 2026.
  • Per Business Quant, the three latest AAWH Cost of Revenue figures stand at $72.1 million (Q1 2026), $75.4 million (Q4 2025), and $81.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Ascend Wellness Holdings 78.95 Mn 18.03 Mn 44.88 Mn 72.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 72.05 Mn
Mar 31, 2026 72.05 Mn
Dec 31, 2025 75.42 Mn
Dec 31, 2025 75.42 Mn
Sep 30, 2025 81.13 Mn
Sep 30, 2025 81.13 Mn
Jun 30, 2025 85.91 Mn
Jun 30, 2025 85.91 Mn
Mar 31, 2025 88.44 Mn
Mar 31, 2025 88.44 Mn
Dec 31, 2024 89.14 Mn
Dec 31, 2024 89.14 Mn
Sep 30, 2024 97.92 Mn
Sep 30, 2024 97.92 Mn
Jun 30, 2024 99.96 Mn
Jun 30, 2024 99.96 Mn
Mar 31, 2024 90.37 Mn
Mar 31, 2024 90.37 Mn
Dec 31, 2023 92.62 Mn
Dec 31, 2023 92.62 Mn